Which has worst prognosis in CLL?
**Core Concept**
Chronic Lymphocytic Leukemia (CLL) is a type of cancer characterized by the clonal expansion of mature lymphocytes, primarily CD5+ B cells. The prognosis of CLL is influenced by several factors, including the presence of specific genetic abnormalities, the number of lymphocytes in the blood, and the patient's overall health.
**Why the Correct Answer is Right**
The worst prognosis in CLL is associated with the presence of 17p deletion, particularly del(17p13.1) involving the TP53 gene. This deletion leads to the loss of function of the p53 tumor suppressor protein, which plays a critical role in DNA repair and cell cycle regulation. The loss of p53 function results in uncontrolled cell growth, increased resistance to chemotherapy, and a higher risk of transformation to aggressive lymphoma. Patients with del(17p) have a significantly poorer response to conventional chemotherapy and a shorter overall survival.
**Why Each Wrong Option is Incorrect**
**Option A:** Deletion of the 13q14.3 locus, which involves the D13S319 and D13S569 microsatellites, is associated with a good prognosis in CLL.
**Option B:** Trisomy 12 is a common cytogenetic abnormality in CLL, but it is not associated with a poor prognosis.
**Option C:** Mutations in the SF3B1 gene are associated with a relatively good prognosis in CLL, particularly in patients with del(11q).
**Clinical Pearl / High-Yield Fact**
In CLL, the presence of a 17p deletion is a critical prognostic factor that guides treatment decisions and predicts a poorer outcome. Clinicians should carefully evaluate cytogenetic and molecular studies to identify high-risk patients who may benefit from more aggressive or innovative therapies.
**Correct Answer:** C.